From Mind To Market - Boehringer Ingelheim

Company profile
The Boehringer Ingelheim group is one of the
world’s 20 leading pharmaceutical companies.
Headquartered in Ingelheim, Germany, it operates
globally with 137 affiliates in 47 countries
and nearly 38,500 employees. Since it was
founded in 1885, the family-owned company
has been committed to researching, developing,
manufacturing and marketing novel products of
high therapeutic value for human and veterinary
medicine.
We invest a large portion of our revenues in
research and development (R&D) and clinical
trials in the search for therapies that fulfil unmet
medical needs for humankind and animals. Our
basic research institutes meanwhile probe scientific
frontiers in search of answers to fundamental
questions about diseases and possible
treatments. Our key therapeutic areas are respiratory,
cardiovascular, metabolism, virology, central
nervous system (CNS), urology, immunology,
and oncology. In all these indication areas we
conduct R&D and clinical studies.
Boehringer Ingelheim: Our Group of Companies
The company’s R&D activities as well as the
production and distribution centres are spread
across the entire globe.
3